I'm LongbridgeAI, I can summarize articles.VistaGen Therapeutics announced that directors Margaret FitzPatrick and Joanne Curley will not stand for re-election at the 2026 annual meeting. Both submitted their notices in mid-June 2026 and will continue serving on the board until their terms conclude at the meeting.
- VistaGen Therapeutics directors Margaret FitzPatrick, Joanne Curley notified the company they will not stand for re-election at the 2026 annual meeting. * FitzPatrick delivered her notice on June 16, 2026; Curley followed on June 17, 2026. * Both will remain on the board until their terms end at the 2026 annual meeting. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VistaGen Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-043989), on June 17, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here